Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

ALLERGAN, INC.

IRVINE, CA US

1. 20110046729 Reinforced Prosthetic Implant With Flexible Shell 02-24-2011
2. 20110046356 POST-TRANSLATIONAL MODIFICATIONS AND CLOSTRIDIAL NEUROTOXINS 02-24-2011
3. 20110046198 KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN 02-24-2011
4. 20110046177 THERAPEUTIC QUINOLINE AND NAPHTHALENE DERIVATIVES 02-24-2011
5. 20110040141 CLOSURE SYSTEM FOR TUBULAR ORGANS - In one embodiment a surgically implantable adjustable ring comprises a ring body which includes a closure system 02-17-2011
6. 20110039900 ISOTHIOZOLES FOR TREATING CONDITIONS OF THE EYE 02-17-2011
7. 20110039866 SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS 02-17-2011
8. 20110039864 THERAPEUTIC COMPOUNDS - Disclosed herein is an alpha-adrenergic compound having a structure 02-17-2011
9. 20110039790 ENHANCED OCULAR NEUROPROTECTION AND NEUROSTIMULATION 02-17-2011
10. 20110038871 CCR2 INHIBITORS FOR TREATING CONDITIONS OF THE EYE 02-17-2011
11. 20110034525 NONSEDATING ALPHA-2 AGONISTS 02-10-2011
12. 20110034517 SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF 02-10-2011
13. 20110034448 CARBONIC ANHYDRASE INHIBITOR SUSTAINED RELEASE INTRAOCULAR DRUG DELIVERY SYSTEMS 02-10-2011
14. 20110028559 SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS 02-03-2011
15. 20110028523 Selective Alpha 2B/2C Agonists - Described herein are compounds useful as agonists of alpha 2B/2C receptors 02-03-2011
16. 20110021595 KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN 01-27-2011
17. 20110020409 Silk Fibroin Hydrogels and Uses Thereof - The present specification provides for methods for purifying fibroins purified fibroins methods of conjugating 01-27-2011
18. 20110015179 COMPOSITIONS FOR TREATING COGNITIVE DISORDERS 01-20-2011
19. 20110014287 Silk Fibroin Hydrogels and Uses Thereof - The present specification provides for methods for purifying fibroins purified fibroins methods of conjugating 01-20-2011
20. 20110014263 Silk Fibroin Hydrogels and Uses Thereof - The present specification provides for methods for purifying fibroins purified fibroins methods of conjugating 01-20-2011
21. 20110009960 PROSTHETIC FABRIC STRUCTURE - Disclosed herein is an implantable prosthesis for breast augmentation or reconstruction procedures 01-13-2011
22. 20110009453 S1P3 RECEPTOR INHIBITORS FOR TREATING INFLAMMATION 01-13-2011
23. 20110008843 PROCESS FOR OBTAINING BOTULINUM NEUROTOXIN 01-13-2011
24. 20110008437 Silk Fibroin Hydrogels and Uses Thereof - The present specification provides for methods for purifying fibroins purified fibroins methods of conjugating 01-13-2011
25. 20110008436 Silk Fibroin Hydrogels and Uses Thereof - The present specification provides for methods for purifying fibroins purified fibroins methods of conjugating 01-13-2011
26. 20110008406 Silk Fibroin Hydrogels and Uses Thereof - The present specification provides for methods for purifying fibroins purified fibroins methods of conjugating 01-13-2011
27. 20110003876 Tetrahydroindoles Having Sphingosine-1-Phosphate Receptor Activity 01-06-2011
28. 20100331430 PHARMACEUTICAL COMPOSITIONS CONTAINING PROPIONIC PRESERVATIVE COMPONENTS 12-30-2010
29. 20100324359 FATIGUE-RESISTANT GASTRIC BANDING DEVICE 12-23-2010
30. 20100324358 HYDRAULIC GASTRIC BAND WITH COLLAPSIBLE RESERVOIR 12-23-2010
31. 20100317872 THERAPEUTIC COMPOUNDS - compound having a substituted five or six-membered carbocycle or heterocycle directly bonded to a substituted aryl or heteroaryl 12-16-2010
32. 20100317595 COMPOSITIONS FOR ENHANCING NAIL GROWTH - compositions and methods for stimulating the growth of nails and cuticles in a mammal, including humans 12-16-2010
33. 20100311808 METHODS, COMPOSITIONS AND DRUG DELIVERY SYSTEMS FOR INTRAOCULAR DELIVERY OF siRNA MOLECULES 12-09-2010
34. 20100310480 DAPSONE TO TREAT ROSASCEA - The methods described herein provide treatment of rosacea using topical formulations of dapsone 12-09-2010
35. 20100305397 HYDRAULIC-MECHANICAL GASTRIC BAND - implantable banding system for treating obesity is disclosed 12-02-2010
36. 20100305047 CYCLOSPORIN DERIVATIVES FOR ENHANCING THE GROWTH OF HAIR 12-02-2010
37. 20100305037 CYCLOSPORIN DERIVATIVES FOR TREATING INFLAMMATORY DISEASES AND CONDITIONS 12-02-2010
38. 20100303798 Methods of Treating Urogenital-Neurological Disorders Using Neurotrophin Retargeted Endopepidases 12-02-2010
39. 20100303794 Methods of Treating Urogenital-Neurological Disorders Using Glucagon Like Hormone Retargeted Endopepidases 12-02-2010
40. 20100303791 Methods of Treating Chronic Neurogenic Inflammation Using Glucagon Like Hormone Retargeted Endopepidases 12-02-2010
41. 20100303789 Methods of Treating Chronic Neurogenic Inflammation Using Neurotrophin Retargeted Endopepidases 12-02-2010
42. 20100303788 Methods of Treating Chronic Neurogenic Inflammation Using Galanin Retargeted Endopepidases 12-02-2010
43. 20100303787 Methods of Treating Urogenital-Neurological Disorders Using Galanin Retargeted Endopepidases 12-02-2010
44. 20100303783 Methods of Treating Urogenital-Neurological Disorders Using Tachykinin Retargeted Endopepidases 12-02-2010
45. 20100303757 Methods of Treating Chronic Neurogenic Inflammation Using Interleukin Retargeted Endopepidases 12-02-2010
46. 20100303756 Methods of Treating Urogenital-Neurological Disorders Using Interleukin Retargeted Endopepidases 12-02-2010
47. 20100298436 EP2 Agonist from Non-Prostanoid Structures Designed as PGE2 Antagonists 11-25-2010
48. 20100298395 UNSUBSTITUTED AND SUBSTITUTED 4-BENZYL-1,3-DIHYDRO-IMIDAZOLE-2-THIONES ACTING AS SPECIFIC OR SELECTIVE ALPHA2 ADRENERGIC AGONISTS AND METHODS FOR USING THE SAME 11-25-2010
49. 20100292790 IMPLANTS AND METHODS FOR MANUFACTURING SAME 11-18-2010
50. 20100292652 NEEDLE CAP - The present invention pertains to a cap for a syringe needle designed to be mounted on the body of a syringe 11-18-2010
51. 20100292293 THERAPEUTIC SUBSTITUTED LACTAMS - Disclosed herein are compounds having a formula: Compositions, methods, and medicaments related thereto are also 11-18-2010
52. 20100286649 IMPLANTABLE DEVICE FASTENING SYSTEM - surgical fastening system for implantable devices is disclosed 11-11-2010
53. 20100286371 Methods of Activating Clostridial Toxins 11-11-2010
54. 20100284958 BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy 11-11-2010
55. 20100280310 Laparoscopic Gastric Band With Active Agents 11-04-2010
56. 20100280250 THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS 11-04-2010
57. 20100280222 CLOSTRIDIAL NEUROTOXIN COMPOSITIONS AND MODIFIED CLOSTRIDIAL NEUROTOXINS 11-04-2010
58. 20100279953 Non-protein stabilized clostridial toxin pharmaceutical compositions 11-04-2010
59. 20100279951 METHOD OF TREATING ALLERGIC CONJUNCTIVITIS WITH CYCLOSPORIN COMPOSITIONS 11-04-2010
60. 20100278898 INTRAOCULAR PRESSURE REDUCTION WITH INTRACAMERAL BIMATOPROST IMPLANTS 11-04-2010
61. 20100278897 INTRAOCULAR BIOACTIVE AGENT DELIVERY SYSTEM WITH MOLECULAR PARTITIONING SYSTEM 11-04-2010
62. 20100278856 BoNT/A PEPTIDES AND METHODSOF PREDICTING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY 11-04-2010
63. 20100274274 ARTIFICIAL GASTRIC VALVE - apparatus and method are disclosed for treating overweight and obese patients by applying a restrictive Artificial Gastric 10-28-2010
64. 20100274194 TWO-WAY SLIT VALVE - slit valve 10 for use with an inflatable medical device having a flange surface 12 with an opening therein 10-28-2010
65. 20100273986 POST-TRANSLATIONAL MODIFICATION AND CLOSTRIDIAL NEUROTOXINS 10-28-2010
66. 20100273985 POST-TRANSLATIONAL MODIFICATIONS AND CLOSTRIDIAL NEUROTOXINS 10-28-2010
67. 20100273814 ((PHENYL)IMIDAZOLYL)METHYLHETEROARYL COMPOUNDS 10-28-2010
68. 20100272754 BOTULINUM TOXIN ADMINISTRATION TO TREAT VARIOUS CONDITIONS 10-28-2010
69. 20100266638 HEADACHE TREATMENT METHOD - Herein disclosed are methods for treating headache such as a chronic migraine for example by administration of botulinum 10-21-2010
70. 20100266622 PREVENTION AND TREATMENT OF OCULAR SIDE EFFECTS WITH A CYCLOSPORIN 10-21-2010
71. 20100256756 SERICIN EXTRACTED FABRICS - Silk is purified to eliminate immunogenic components and is used to form fabric that is used to form tissue-supporting 10-07-2010
72. 20100256594 MULTI-SITE INJECTION SYSTEM - in accordance with the present invention generally includes a plurality of medicament delivering needles/microprotrusions 10-07-2010
73. 20100256385 PROSTAGLANDIN E RECEPTOR ANTAGONISTS - prostaglandin receptor antagonist compounds represented by the general formula I, STR00001 wherein A, R, R 10-07-2010
74. 20100255068 HAIR-LIKE SHAPED HYDROGELS FOR SOFT TISSUE AUGMENTATION 10-07-2010
75. 20100249924 BIOERODIBLE MATRIX FOR TISSUE INVOLVEMENT 09-30-2010
76. 20100249069 S1P3 RECEPTOR INHIBITORS FOR TREATING PAIN 09-30-2010
77. 20100247606 INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEMS AND METHODS FOR TREATING OCULAR CONDITIONS 09-30-2010
78. 20100240699 METHOD OF TREATING SENSORIMOTOR DISORDERS WITH ALPHA-2 ADRENERGIC RECEPTOR AGONISTS 09-23-2010
79. 20100240614 Indole Compounds Bearing Aryl or Heteroaryl Groups Having Sphingosine 1-Phosphate (S1P) Receptor Biological Activity 09-23-2010
80. 20100234944 BREAST IMPLANT SELECTOR SYSTEMS - breast implant selector system including a breast width selector for selecting breast width input information 09-16-2010
81. 20100233802 CELLS USEFUL FOR IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS 09-16-2010
82. 20100233741 IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS 09-16-2010
83. 20100228347 FLUSH PATCH FOR ELASTOMERIC IMPLANT SHELL 09-09-2010
84. 20100227868 TREATMENT METHODS WITH BRIMONIDINE - Disclosed herein are therapeutic methods related to brimonidine 09-09-2010
85. 20100227822 TARGETED DELIVERY OF BOTULINUM TOXIN TO THE SPHENOPALATINE GANGLION 09-09-2010
86. 20100226988 CROSS-LINKING OF LOW-MOLECULAR WEIGHT AND HIGH-MOLECULAR WEIGHT POLYSACCHARIDES, PREPARATION OF INJECTABLE MONOPHASE HYDROGELS, POLYSACCHARIDES AND HYDROGELS OBTAINED 09-09-2010
87. 20100222587 COMPOSITIONS AND METHODS FOR THE INTRAOCULAR TRANSPORT OF THERAPEUTIC AGENTS 09-02-2010
88. 20100217403 SWELLABLE HYALURONIC ACID PARTICLES - The present invention generally relates to particles comprising hyaluronic acid, wherein the particles are coated 08-26-2010
89. 20100217198 IMPLANTABLE ACCESS PORT DEVICE HAVING A SAFETY CAP 08-26-2010
90. 20100216857 METHOD OF TREATING MOTOR DISORDERS WITH 4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE-2(3H)-THIONE 08-26-2010
91. 20100210689 THERAPEUTIC SUBSTITUTED CHLOROCYCLOPENTANOLS 08-19-2010
92. 20100209405 SERICIN EXTRACTED SILKWORM FIBROIN FIBERS 08-19-2010
93. 20100204335 KIT AND COMPOSITION FOR EYELASH GROWTH - kit for enhancing the appearance of eyelashes, comprising an eyelash enhancing composition and delivery system 08-12-2010
94. 20100204325 VALPROIC ACID DRUG DELIVERY SYSTEMS AND INTRAOCULAR THERAPEUTIC USES THEREOF 08-12-2010
95. 20100204127 USE OF A BOTULINUM NEUROTOXIN TO ALLEVIATE VARIOUS DISORDERS 08-12-2010
96. 20100204126 THERAPY FOR MELANIN RELATED AFFLICTIONS - Methods for treating melanin related afflictions by local administration of a Clostridial toxin 08-12-2010
97. 20100203559 Immuno-Based Botulinum Toxin Serotype A Activity Assays 08-12-2010
98. 20100197730 METHODS FOR TREATING ANXIETY - Disclosed are methods of treating anxiety by administering to a patient in need of such treatment a compound having the 08-05-2010
99. 20100197729 THERAPEUTIC ((PHENYL)IMIDAZOLYL)METHYLQUINOLINYL COMPOUNDS 08-05-2010
100. 20100190823 Therapeutic ((Bicylicheteroaryl)Imidazolyl) Methylheteroaryl Compounds 07-29-2010
101. 20100190792 METHODS FOR TREATING COGNITIVE DISORDERS USING 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS 07-29-2010
102. 20100189655 METHODS FOR TREATING HEADACHE - headache can be treated more effectively by co-administration of a botulinum toxin and a triptan drug to a patient 07-29-2010
103. 20100185205 INTEROCULAR INJECTOR - intraocular injector includes a syringe body having open-ended cone disposed in one end thereof along with a piston disposed in 07-22-2010
104. 20100185049 DOME AND SCREW VALVES FOR REMOTELY ADJUSTABLE GASTRIC BANDING SYSTEMS 07-22-2010
105. 20100184664 OPHTHALMIC COMPOSITIONS USEFUL FOR IMPROVING VISUAL ACUITY 07-22-2010
106. 20100183696 Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists 07-22-2010
107. 20100178414 SYSTEM AND METHOD FOR MOLDING SOFT FLUID-FILLED IMPLANT SHELLS 07-15-2010
108. 20100174307 REMOTE DEFLATION OF INTRAGASTRIC BALLOON 07-08-2010
109. 20100173981 THERAPEUTIC COMPOUNDS - Disclosed herein is a compound according to one of the formulas or a pharmaceutically acceptable salt thereof 07-08-2010
110. 20100168783 INTRAGASTRIC BALLOON RETRIEVAL MECHANISMS 07-01-2010
111. 20100168780 BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS 07-01-2010
112. 20100168199 Kinase Inhibitors - organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate 07-01-2010
113. 20100168189 THERAPEUTIC SUBSTITUTED LACTAMS - Therapeutic compounds, compositions, methods, and medicaments related thereto are disclosed herein 07-01-2010
114. 20100161052 BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS 06-24-2010
115. 20100160948 BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS 06-24-2010
116. 20100160609 Chimera Botulinum Toxin Type E - toxin comprising a modified light chain of a botulinum toxin type E 06-24-2010
117. 20100160407 THERAPEUTIC SUBSTITUTED CYCLIC LACTAMS - Disclosed and described herein is a compound having a formula therapeutic methods medicaments and compositions 06-24-2010
118. 20100152679 INJECTION DEVICE - includes a syringe having a body with a piston disposed therein with an open end along with a viscous fluid disposed in the body for 06-17-2010
119. 20100151494 FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS 06-17-2010
120. 20100145061 N-(1-PHENYL-2-ARYLETHYL)-4,5-DIHYDRO-2H-PYRROL-5-AMINE COMPOUNDS AS SUBTYPE SELECTIVE MODULATORS OF ALPHA2B OR ALPHA2B AND ALPHA2C ADRENOCEPTORS 06-10-2010
121. 20100144609 METHODS USING CYCLOSPORIN IN TREATING PATIENTS WITH INTRAOCULAR LENSES 06-10-2010
122. 20100137813 LUER CONNECTORS, COMPONENTS THEREOF AND FLUENT MATERIAL DELIVERY DEVICES UTILIZING THE SAME 06-03-2010
123. 20100137747 CLINICAL ASSESSMENT SCALES AND METHODS - Disclosed herein are scales for assessing lip fullness severity of perioral lines at rest severity of perioral 06-03-2010
124. 20100137347 SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS 06-03-2010
125. 20100129449 Cosmetic Neurotoxin Compositions and Methods 05-27-2010
126. 20100129435 Methods and compositions for treatment of ocular neovascularization and neural injury 05-27-2010
127. 20100124565 BIODEGRADABLE ALPHA-2 AGONIST POLYMERIC IMPLANTS AND THERAPEUTIC USES THEREOF 05-20-2010
128. 20100124559 Early Treatment and Prevention of Increased Muscle Tonicity 05-20-2010
129. 20100121223 Clinical Assessment Scales and Methods - Disclosed herein are scales for assessing eyelash prominence 05-13-2010
130. 20100121042 CHIMERA BOTULINUM TOXIN TYPE E - toxin comprising a modified light chain of a botulinum toxin type E 05-13-2010
131. 20100113516 QUINOLYNYLMETHYLIMIDIZOLES AS THERAPEUTIC AGENTS 05-06-2010
132. 20100112610 Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides 05-06-2010
133. 20100112609 Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides 05-06-2010
134. 20100112082 Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides 05-06-2010
135. 20100111962 Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides 05-06-2010
136. 20100105687 METHODS FOR TREATING COGNITIVE DISORDERS USING 1-ARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 1-HETEROARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS 04-29-2010
137. 20100104654 PROSTAGLANDIN AND PROSTAMIDE DRUG DELIVERY SYSTEMS AND INTRAOCULAR THERAPEUTIC USES THEREOF 04-29-2010
138. 20100099945 ELECTRICALLY ACTIVATED VALVE FOR IMPLANTABLE FLUID HANDLING SYSTEM 04-22-2010
139. 20100099655 IMPLANTS AND METHODS FOR TREATING INFLAMMATION-MEDIATED CONDITIONS OF THE EYE 04-22-2010
140. 20100099624 CROSS-LINKED COLLAGEN AND USES THEREOF - The present invention discloses collagen cross-linked in a micro to non-fibrillar form and at a high 04-22-2010
141. 20100099623 Cross-Linked Collagen and Uses Thereof - The present invention discloses collagen cross-linked in a micro to non-fibrillar form and at a high 04-22-2010
142. 20100098772 DRUG DELIVERY SYSTEMS AND METHODS FOR TREATING NEOVASCULARIZATION 04-22-2010
143. 20100098764 POLYSACCHARIDE GEL FORMULATION HAVING MULTI-STAGE BIOACTIVE AGENT DELIVERY 04-22-2010
144. 20100098727 METHODS FOR TREATING EYE DISORDERS - Methods of treating an eye disorder are disclosed 04-22-2010
145. 20100093809 THERAPEUTIC SUBSTITUTED THIAZOLIDINONES, OXAZOLIDINONES, AND RELATED COMPOUNDS 04-15-2010
146. 20100093793 METHODS FOR TREATING COGNITIVE DISORDERS USING 3-ARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES, 3-HETEROARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS 04-15-2010
147. 20100093729 SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS 04-15-2010
148. 20100087843 Mechanical Gastric Band With Cushions - system for regulating the functioning of an organ or duct generally includes an implantable band structured to 04-08-2010
149. 20100087503 KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN 04-08-2010
150. 20100081631 METHODS AND COMPOSITIONS FOR TREATING GASTROINTENSTIAL DISORDERS 04-01-2010
151. 20100081158 FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS 04-01-2010
152. 20100081157 FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS 04-01-2010
153. 20100081156 FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY 04-01-2010
154. 20100081155 FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY 04-01-2010
155. 20100076194 SUBSTITUTED 3-AMINO-1-OXO OR THIOXO-1,2,5,6,7,8-HEXAHYDRO-2,7-NAPHTHYRIDINE-4-CARBONITRILES ARE SELECTIVE ALPHA 2B ANTAGONISTS 03-25-2010
156. 20100076020 QUINOLYNYLMETHYLIMIDIZOLES AS THERAPEUTIC AGENTS 03-25-2010
157. 20100075396 Botulinum Neurotoxin Serotype B Activatable Botulinum Neurotoxin Serotype Bs 03-25-2010
158. 20100075358 FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS 03-25-2010
159. 20100075357 FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS 03-25-2010
160. 20100075346 FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS 03-25-2010
161. 20100074957 INTRAOCULAR FORMULATION - Biodegradable therapeutic agent incorporating microspheres formulated in a high viscosity carrier suitable for intraocular 03-25-2010
162. 20100069610 SUBSTRATES USEFUL FOR FRET PROTEASE ASSAYS FOR BOTULINUM SEROTYPE A/E TXOINS 03-18-2010
163. 20100068244 STABILIZED BIODEGRADABLE NEUROTOXIN IMPLANTS 03-18-2010
164. 20100063303 THERAPEUTIC COMPOUNDS - Compound having the formula below are disclosed herein: formula 03-11-2010
165. 20100063017 Ophthalmic Suspension for Ocular Use - gatifloxacin and prednisolone topical ophthalmic pharmaceutical compositions for prevention and treatment of 03-11-2010
166. 20100056547 OPHTHALMIC COMPOSITIONS COMPRISING dDC - composition comprising dDC and a polymer wherein the composition is an aqueous liquid with a viscosity which 03-04-2010
167. 20100055727 FRET PROTEASE ASSAYS FOR BOTULINUM SEROTYPE A/E TOXINS 03-04-2010
168. 20100049317 SELF-SEALING SHELL FOR INFLATABLE PROSTHESES 02-25-2010
169. 20100049316 SELF-SEALING SHELL FOR INFLATABLE PROSTHESES 02-25-2010
170. 20100049214 IMPLANTABLE MEDICAL IMPLANTS HAVING FASTENERS AND METHODS OF FASTENING 02-25-2010
171. 20100048669 THERAPEUTIC COMPOUNDS - Disclosed herein are compounds of the formula STR00001 therapeutic methods, compositions, and medicaments related thereto are 02-25-2010
172. 20100048664 THERAPEUTIC SUBSTITUTED PYRROLES - Disclosed herein is a compound represented by a formula: STR00001 Therapeutic methods compositions 02-25-2010
173. 20100048642 METHODS FOR TREATING COGNITIVE DISORDERS 02-25-2010
174. 20100042212 Soft Filled Prosthesis Shell With Discrete Fixation Surfaces 02-18-2010
175. 20100042211 SOFT FILLED PROSTHESIS SHELL WITH DISCRETE FIXATION SURFACES 02-18-2010
176. 20100042052 METHODS OF OPERATING AN IMPLANTABLE INJECTION PORT SYSTEM 02-18-2010
177. 20100041715 SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ANTAGONISTS AND METHODS FOR USE THEREOF 02-18-2010
178. 20100029781 METHODS FOR PREPARATION OF ANTI-ACNE FORMULATION AND COMPOSITIONS PREPARED THEREBY 02-04-2010
179. 20100029735 THERAPEUTIC COMPOUNDS - Disclosed herein is a compound of the formula 02-04-2010
180. 20100029618 ALPHA-2 RECEPTOR PAN AGONIST AND ANTICONVULSANT COMPOSITIONS FOR TREATING CHRONIC PAIN 02-04-2010
181. 20100028438 Hyaluronic Acid-Based Gels Including Lidocaine 02-04-2010
182. 20100028437 Hyaluronic Acid-Based Gels Including Lidocaine 02-04-2010
183. 20100028385 TREATMENT OF EXCESS CERUMEN SECRETION - Presently descibed are methods useful in treating outer ear conditions generally associated with the secretion 02-04-2010
184. 20100016355 ALPHA-2B ADRENERGIC RECEPTOR AGONIST AND SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR COMPOSITIONS FOR TREATING CHRONIC PAIN 01-21-2010
185. 20100015158 METHOD FOR TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION 01-21-2010
186. 20100010291 IMPLANTABLE PUMP SYSTEM WITH CALIBRATION 01-14-2010
187. 20100010027 ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE 01-14-2010
188. 20100009985 THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS 01-14-2010
189. 20100009953 CYCLOSPORIN DERIVATIVES FOR TREATING OCULAR AND DERMAL DISEASES AND CONDITIONS 01-14-2010
190. 20100004305 NAPHTHYLMETHYLIMIDIZOLES AS THERAPEUTIC AGENTS 01-07-2010
191. 20100004198 POLYSACCHARIDE GEL FORMULATION HAVING INCREASED LONGEVITY 01-07-2010
192. 20090326654 FILLABLE PROSTHETIC IMPLANT WITH GEL-LIKE PROPERTIES 12-31-2009
193. 20090326034 KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN 12-31-2009
194. 20090325970 AZA-INDOLES AND RELATED COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ANTAGONIST BIOLOGICAL ACTIVITY 12-31-2009
195. 20090318872 IMPLANTABLE DEVICE FASTENING SYSTEM AND METHODS OF USE 12-24-2009
196. 20090318499 COMPOUNDS HAVING ANALGESIC AND/OR IMMUNOSTIMULANT ACTIVITY 12-24-2009
197. 20090318449 THERAPEUTIC LACTAMS - Compounds comprising STR00001 or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein J 12-24-2009
198. 20090318404 SUBSTITUTED BETA-LACTAMS - Disclosed herein is a compound comprising STR00001 or a pharmaceutically acceptable salt or a prodrug or a metabolite thereof 12-24-2009
199. 20090318360 Use of the neurotoxic component of a botulinum toxin for treating arthritis 12-24-2009
200. 20090317839 BOTULINUM TOXIN SCREENING ASSAYS - Methods for detecting BoNT/A activity in a sample methods for screening molecules able to compete with BoNT/A 12-24-2009
201. 20090312785 Implantable Pump System - remotely adjustable gastric band system is provided 12-17-2009
202. 20090312337 COMPOSITIONS CONTAINING ALPHA-2-ADRENERGIC AGONIST COMPONENTS 12-17-2009
203. 20090312305 BICYCLIC COMPOUNDS HAVING ACTIVITY AT THE CXCR4 RECEPTOR 12-17-2009
204. 20090306398 METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS 12-10-2009
205. 20090306161 METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS 12-10-2009
206. 20090304748 CLOSTRIDIAL TOXIN PHARMACEUTICAL COMPOSITIONS 12-10-2009
207. 20090299328 Injection device for soft-tissue augmentation fillers, bioactive agents and other biocompatible materials in liquid or gel form 12-03-2009
208. 20090298753 METHODS FOR THE THERAPEUTIC USE OF CYCLOSPORINE COMPONENTS 12-03-2009
209. 20090287161 METERED, MULTIPLE DOSE/ALIQUOT SYRINGE - metered multiple aliquot/dose syringe includes a barrel having an open end and a opposing spaced apart port 11-19-2009
210. 20090286842 NAPHTHYLMETHYLIMIDIZOLES AS THERAPEUTIC AGENTS 11-19-2009
211. 20090286829 QUINOLYNYLMETHYLIMIDIZOLES AS THERAPEUTIC AGENTS 11-19-2009
212. 20090286787 SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS 11-19-2009
213. 20090286773 Kinase inhibitors - drug delivery systems comprising ocular implant which include organic molecules 11-19-2009
214. 20090281322 THERAPEUTICALLY USEFUL SUBSTITUTED 1,7-DIPHENYL-1,2,3,5,6,7-HEXAHYDROPYRIDO[3,2,1-Ij]QUINOLINE COMPOUNDS 11-12-2009
215. 20090281171 THERAPEUTIC SUBSTITUTED THIAZOLIDINONES, OXAZOLIDINONES, AND RELATED COMPOUNDS 11-12-2009
216. 20090281104 Therapeutic Compounds - Compounds comprising STR00001 or a pharmaceutically acceptable salt or a prodrug thereof are disclosed 11-12-2009
217. 20090281102 THERAPEUTIC N-ARYL OR N-HETEROARYL PYRAZOLIDINE AND PYRAZOLIDINONE DERIVATIVES 11-12-2009
218. 20090281101 THERAPEUTIC SUBSTITUTED HYDANTOINS, AND RELATED COMPOUNDS 11-12-2009
219. 20090281085 3-(4-FLUOROPHENYL)-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS HAVING ANALGESIC ACTIVITY 11-12-2009
220. 20090275646 THERAPEUTIC COMPOUNDS - Compounds having a structure STR00001 are disclosed herein 11-05-2009
221. 20090275627 ALPHA2B AND ALPHA2C AGONISTS - Described herein are compounds that can be useful as bioactive agents 11-05-2009
222. 20090274729 MEDIA FOR CLOSTRIDIUM BACTERIUM AND PROCESSES FOR OBTAINING A CLOSTRIDIAL TOXIN 11-05-2009
223. 20090270985 Flush Patch For Elastomeric Implant Shell 10-29-2009
224. 20090270904 Remotely Adjustable Gastric Banding System 10-29-2009
225. 20090270396 THERAPEUTIC COMPOUNDS - Compounds comprising STR00001 or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein J 10-29-2009
226. 20090270392 SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS 10-29-2009
227. 20090270387 SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS 10-29-2009
228. 20090270386 THERAPEUTIC COMPOUNDS - Compounds comprising STR00001 or a pharmaceutically acceptable salt or a prodrug thereof are disclosed 10-29-2009
229. 20090270385 SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS 10-29-2009
230. 20090264901 IMPLANTABLE ACCESS PORT DEVICE AND ATTACHMENT SYSTEM 10-22-2009
231. 20090264827 METHODS OF IMPLANTING AN INJECTION PORT - surgical fastening system for implantable devices is disclosed 10-22-2009
232. 20090264813 APPARATUS AND METHODS FOR IMPLANTING PARTICULATE OCULAR IMPLANTS 10-22-2009
233. 20090263836 BOTULINUM TOXIN SCREENING ASSAYS - Methods for detecting BoNT/A activity in a sample methods for screening molecules able to compete with BoNT/A 10-22-2009
234. 20090263426 METHODS FOR TREATING HEADACHE - headache can be treated more effectively by co-administration of a botulinum toxin and a triptan drug to a patient 10-22-2009
235. 20090259231 IMPLANTABLE DEVICE FASTENING SYSTEM AND METHODS OF USE 10-15-2009
236. 20090259191 IMPLANTABLE INJECTION PORT - surgical fastening system for implantable devices is disclosed 10-15-2009
237. 20090259190 IMPLANTABLE INJECTION PORT AND PROTECTIVE CAP 10-15-2009
238. 20090258924 METHODS, COMPOSITIONS AND DRUG DELIVERY SYSTEMS FOR INTRAOCULAR DELIVERY OF siRNA MOLECULES 10-15-2009
239. 20090254052 IMPLANTABLE DEVICE FASTENING SYSTEM AND METHODS OF USE 10-08-2009
240. 20090252802 Compositions Including Relatively Water Insoluble/Unwettable Drugs And Methods For Using Same 10-08-2009
241. 20090252764 SUTURE LINE ADMINISTRATION TECHNIQUE USING BOTULINUM TOXIN 10-08-2009
242. 20090247594 THERAPEUTIC COMPOUNDS - Disclosed herein is a compound having a structure STR00001 or a pharmaceutically acceptable salt thereof, or a prodrug thereof 10-01-2009
243. 20090247527 SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS 10-01-2009
244. 20090239930 THERAPEUTIC COMPOUNDS - Compounds comprising STR00001 or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein Y, A, R 09-24-2009
245. 20090239918 SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF 09-24-2009
246. 20090239869 THERAPEUTIC SUBSTITUTED CYCLOPENTANES - Therapeutic compounds are disclosed herein 09-24-2009
247. 20090239867 THERAPEUTIC SUBSTITUTED GAMMA LACTAMS - Disclosed herein is a compound comprising STR00001 or a pharmaceutically acceptable salt or a prodrug thereof 09-24-2009
248. 20090239858 THERAPEUTIC AMIDES - Compounds comprising STR00001 or a pharmaceutically acceptable salt or a prodrug thereof are disclosed 09-24-2009
249. 20090232850 THERAPEUTIC TREATMENTS USING BOTULINUM NEUROTOXIN 09-17-2009
250. 20090221585 NOVEL COMPOUNDS AND THEIR USE RELATED TO COMPOSITIONS FOR TREATING DISEASE 09-03-2009
251. 20090220568 METHODS FOR TREATING A STRICTURE WITH A BOTULINUM TOXIN 09-03-2009
252. 20090215740 THERAPEUTIC SUBSTITUTED BETA-LACTAMS - compound having a structure STR00001 is disclosed herein 08-27-2009
253. 20090214685 SUSTAINED RELEASE POLOXAMER CONTAINING PHARMACEUTICAL COMPOSITIONS 08-27-2009
254. 20090209538 THERAPEUTIC SUBSTITUTED LACTAMS - Herein are described compounds having a structure STR00001 or a pharmaceutically acceptable salt thereof, wherein Y, 08-20-2009
255. 20090203660 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods 08-13-2009
256. 20090203659 METHOD OF ENHANCING HAIR GROWTH - Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a 08-13-2009
257. 20090202591 LEUCINE-BASED MOTIF AND CLOSTRIDIAL NEUROTOXINS 08-13-2009
258. 20090197962 SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY 08-06-2009
259. 20090197898 SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF 08-06-2009
260. 20090197847 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods 08-06-2009
261. 20090197846 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods 08-06-2009
262. 20090196906 Kinase inhibitors - drug delivery systems comprising ocular implant which include organic molecules 08-06-2009
263. 20090196905 STABILIZATION OF MITOCHONDRIAL MEMBRANES IN OCULAR DISEASES AND CONDITIONS 08-06-2009
264. 20090192159 SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS 07-30-2009
265. 20090192151 THERAPEUTIC AMIDES AND RELATED COMPOUNDS 07-30-2009
266. 20090191583 CLOSTRIDIAL TOXIN ACTIVITY ASSAYS - Compositions useful for detecting Clostridial toxin activity comprising a cell that contains an exogenous 07-30-2009
267. 20090186885 THERAPEUTIC COMPOUNDS - Disclosed herein is a compound according to one of the formulas STR00001 wherein R Additionally pharmaceutically acceptable salt 07-23-2009
268. 20090186866 THERAPEUTIC BETA-LACTAMS - Compounds comprising STR00001 or a pharmaceutically acceptable salt or a prodrug thereof are disclosed 07-23-2009
269. 20090182356 REMOTELY ADJUSTABLE GASTRIC BANDING DEVICE 07-16-2009
270. 20090181969 Hypotensive Lipid And Timolol Compositions And Methods Of Using Same 07-16-2009
271. 20090181104 BREAST RECONSTRUCTION OR AUGMENTATION USING COMPUTER-MODELED DEPOSITION OF PROCESSED ADIPOSE TISSUE 07-16-2009
272. 20090176828 4-(CONDENSED CYCLICMETHYL)-IMIDAZOLE-2-THIONES ACTING AS ALPHA2 ADRENERGIC AGONISTS 07-09-2009
273. 20090163560 THERAPEUTIC N-ARYL OR N-HETEROARYL PYRAZOLIDINE AND PYRAZOLIDINONE DERIVATIVES 06-25-2009
274. 20090163550 RETINOID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED METHODS 06-25-2009
275. 20090156568 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods 06-18-2009
276. 20090155314 Dermal filler - Improved dermal filler formulation comprising a hyaluronic acid and a botulinum toxin 06-18-2009
277. 20090149953 FORM STABLE BREAST IMPLANT SIZER AND METHOD OF USE 06-11-2009
278. 20090149546 Enhanced Bimatoprost Ophthalmic Solution 06-11-2009
279. 20090149435 PROCESS FOR MAKING A PHARMACEUTICAL COMPOSITION 06-11-2009
280. 20090148527 INTRAOCULAR FORMULATION - Biodegradable therapeutic agent incorporating microspheres formulated in a high viscosity carrier suitable for intraocular 06-11-2009
281. 20090148499 FORMULATION FOR CONTROLLED RELEASE OF DRUGS BY COMBINING HYDROPHILIC AND HYDROPHOBIC AGENTS 06-11-2009
282. 20090143746 LUER CONNECTORS, COMPONENTS THEREOF AND FLUENT MATERIAL DELIVERY DEVICES UTILIZING THE SAME 06-04-2009
283. 20090143461 SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY 06-04-2009
284. 20090143348 POLYSACCHARIDE GEL COMPOSITIONS AND METHODS FOR SUSTAINED DELIVERY OF DRUGS 06-04-2009
285. 20090143331 POLYSACCHARIDE GEL FORMULATION HAVING INCREASED LONGEVITY 06-04-2009
286. 20090131968 PRESSURE SENSING INTRAGASTRIC BALLOON - intragastric balloon having a built-in sensor 05-21-2009
287. 20090131307 PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLOSPORINS 05-21-2009
288. 20090124790 CHROMATOGRAPHIC METHOD AND SYSTEM FOR PURIFYING A BOTULINUM TOXIN 05-14-2009
289. 20090124676 SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY 05-14-2009
290. 20090123498 TREATMENT OF POST-STROKE MUSCLE PAIN - method and composition for treating a patient suffering from a disease disorder or condition and associated pain 05-14-2009
291. 20090123497 CHROMATOGRAPHIC METHOD AND SYSTEM FOR PURIFYING A BOTULINUM TOXIN 05-14-2009
292. 20090118829 SOFT PROSTHESIS SHELL TEXTURING METHOD - method of texturing a soft prosthetic implant shell, such as a silicone breast implant shell 05-07-2009
293. 20090118738 NEEDLESS APPLICATOR SYSTEM AND METHOD FOR APPLICATION OF MEDICAMENT TO THE BACK OF AN EYE 05-07-2009
294. 20090118703 DRUG DELIVERY SYSTEMS AND METHODS - delivery system includes a housing along with a tip connected to one end of the housing 05-07-2009
295. 20090118475 Clostridial Neurotoxin Compositions and Modified Clostridial Neurotoxins 05-07-2009
296. 20090118247 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods 05-07-2009
297. 20090118246 Therapeutic ophthalmic compositions containing retinal friendly recpients and related methods 05-07-2009
298. 20090117572 Cell-Based Fluorescence Resonance Energy Transfer (FRET) Assays For Clostridial Toxins 05-07-2009
299. 20090117157 METHODS OF TREATING UROGENITAL-NEUROLOGICAL DISORDERS USING MODIFIED CLOSTRIDIAL TOXINS 05-07-2009
300. 20090104234 METHODS OF TREATING CHRONIC NEUROGENIC INFLAMMATION USING MODIFIED CLOSTRIDIAL TOXINS 04-23-2009
301. 20090099249 THERAPEUTIC LACTAMS - Disclosed herein is a compound having a structure STR00001 Therapeutic methods compositions and medicaments related thereto are 04-16-2009
302. 20090093755 CROSSED-LINKED HYALURONIC ACID AND COLLAGEN AND USES THEREOF 04-09-2009
303. 20090088433 METHODS OF USING AS ANALGESICS 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS 04-02-2009
304. 20090087459 METHODS FOR TREATING EYE DISORDERS - methods of treating an eye disorder 04-02-2009
305. 20090087458 ACTIVATABLE RECOMBINANT NEUROTOXINS - Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom 04-02-2009
306. 20090082796 MODIFIED TENOTOMY SCISSORS WITH CONJUNCTIVA RISERS 03-26-2009
307. 20090082793 RELEASABLY-SECURABLE ONE-PIECE ADJUSTABLE GASTRIC BAND 03-26-2009
308. 20090082321 STEROID CONTAINING DRUG DELIVERY SYSTEMS 03-26-2009
309. 20090081730 ACTIVATABLE RECOMBINANT NEUROTOXINS - Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom 03-26-2009
310. 20090081277 PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATING OCULAR CONDITIONS 03-26-2009
311. 20090069309 PROSTAGLANDIN ANALOGS - Compounds comprising STR00001 or a pharmaceutically acceptable salt or a prodrug thereof is disclosed herein 03-12-2009
312. 20090062361 THERAPEUTIC HYDANTOINS - Disclosed herein is a compound represented by a formula STR00001 Therapeutic methods compositions 03-05-2009
313. 20090062344 THERAPEUTIC SUBSTITUTED PIPERIDONE COMPOUNDS 03-05-2009
314. 20090062249 METHODS FOR REDUCING OR PREVENTING TRANSPLANT REJECTION IN THE EYE AND INTRAOCULAR IMPLANTS FOR USE THEREFOR 03-05-2009
315. 20090054505 THERAPEUTIC OXAZOLIDINONES AND THIAZOLIDINONES 02-26-2009
316. 20090048431 MULTIVALENT CLOSTRIDIAL TOXINS - multivalent Clostridial toxin comprising more than one binding domain directed to a cell surface molecule of a target 02-19-2009
317. 20090048302 Methods and compositions for the treatment of conditions related to gastric acid secretion 02-19-2009
318. 20090042270 ACTIVATABLE RECOMBINANT NEUROTOXINS - Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom 02-12-2009
319. 20090042231 FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS 02-12-2009
320. 20090041805 BOTULINUM TOXIN FOR TREATING POSTHERPETIC NEURALGIA 02-12-2009
321. 20090036436 3-ARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES, 3-HETEROARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS HAVING ANALGESIC AND/OR IMMUNO STIMULANT ACTIVITY 02-05-2009
322. 20090036403 Tunably Crosslinked Polysaccharide Compositions 02-05-2009
323. 20090030515 ALL-BARRIER ELASTOMERIC GEL-FILLED BREAST PROSTHESIS 01-29-2009
324. 20090030367 SOFT TISSUE AUGMENTATION BY NEEDLE-FREE INJECTION 01-29-2009
325. 20090030188 ACTIVATABLE RECOMBINANT NEUROTOXINS - Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom 01-29-2009
326. 20090030182 ACTIVATABLE RECOMBINANT NEUROTOXINS - Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom 01-29-2009
327. 20090028908 METHODS FOR TREATING NEUROGENIC INFLAMMATION 01-29-2009
328. 20090023901 Degradable Clostridial Toxins - The specification discloses modified Clostridial toxins comprising a PAR ligand domain a Clostridial toxin enzymatic 01-22-2009
329. 20090023198 OPTIMIZING EXPRESSION OF ACTIVE BOTULINUM TOXIN TYPE A 01-22-2009
330. 20090022808 Coated Hyaluronic Acid Particles - The present invention generally relates to particles comprising hyaluronic acid, wherein the particles are coated or 01-22-2009
331. 20090022763 ANIMAL PRODUCT FREE MEDIA AND PROCESSES FOR OBTAINING A BOTULINUM TOXIN 01-22-2009
332. 20090018168 THERAPEUTIC SUBSTITUTED CHLOROCYCLOPENTANOLS 01-15-2009
333. 20090018081 ACTIVATABLE CLOSTRIDIAL TOXINS - Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom 01-15-2009
334. 20090017071 METHODS FOR TREATING NEUROGENIC INFLAMMATION 01-15-2009
335. 20090016981 THERAPEUTIC COMPOUNDS - compound having a structure STR00001 is disclosed herein 01-15-2009
336. 20090012145 THERAPEUTIC ESTERS - compound comprising STR00001 or a pharmaceutically acceptable salt or a prodrug thereof 01-08-2009
337. 20090010967 CLOSTRIDIAL TOXIN DERIVATIVES AND METHODS FOR TREATING PAIN 01-08-2009
338. 20090004680 DETERMINING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY USING BOTULINUM TOXIN A PEPTIDES 01-01-2009
339. 20090004225 TOXIN COMPOUNDS WITH ENHANCED MEMBRANE TRANSLOCATION CHARACTERISTICS 01-01-2009
340. 20080319013 4-(SUBSTITUTED CYCLOALKYLMETHYL) IMIDAZOLE-2-THIONES, 4-(SUBSTITUTED CYCLOALKENYLMETHYL) IMIDAZOLE-2-THIONES, 4-(SUBSTITUTED CYCLOALKYLMETHYL) IMIDAZOLE-2-ONES AND, 4-(SUBSTITUTED CYCLOALKYLMETHYL) IMIDAZOLE-2-ONES AND RELATED COMPOUNDS 12-25-2008
341. 20080318986 Ddc Compositions - composition comprising from 1% to 3% dDC which is aqueous and ophthalmically acceptable is disclosed herein 12-25-2008
342. 20080312321 THERAPEUTIC SUBSTITUTED CYCLOPENTANES - Therapeutic compounds are disclosed herein 12-18-2008
343. 20080312236 3-Heteroaryl-3-Hydroxy-2-Amino-Propyl Amines And Related Compounds Having Analgesic And/Or Immuno Stimlant Activity 12-18-2008
344. 20080311622 ACTIVATABLE RECOMBINANT NEUROTOXINS - Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom 12-18-2008
345. 20080305510 FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY 12-11-2008
346. 20080305509 FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY 12-11-2008
347. 20080300681 BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS 12-04-2008
348. 20080300315 Stabilized Compositions Comprising a Therapeutically Active Agent, and an Oxidizing Preservative 12-04-2008
349. 20080300269 THERAPEUTIC COMPOUNDS - Disclosed herein are compounds of the formula or salts or bioisosteres thereof 12-04-2008
350. 20080299178 SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR PREVENTING RETINAL DYSFUNCTION 12-04-2008
351. 20080293637 Cross-linked collagen and uses thereof - The present invention discloses collagen cross-linked in a micro to non-fibrillar form and at a high 11-27-2008
352. 20080293085 FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY 11-27-2008
353. 20080293084 FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY 11-27-2008
354. 20080292679 BIODEGRADABLE DRUG DELIVERY SYSTEM - drug delivery system comprised of segmented biodegradable implants sized and suitable for implantation in an ocular 11-27-2008
355. 20080286336 OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCESS 11-20-2008
356. 20080286334 OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCESS 11-20-2008
357. 20080279895 TARGETED DELIVERY OF BOTULINUM TOXIN TO THE SPHENOPALATINE GANGLION 11-13-2008
358. 20080274480 Botulinum Toxin Type a Immunoresistant Assay 11-06-2008
359. 20080269498 THERAPEUTIC SUBSTITUTED LACTAMS - Therapeutic compounds, compositions, medicaments, and methods are disclosed herein 10-30-2008
360. 20080269181 METHODS FOR TREATING A POSTERIOR SEGMENT OF AN EYE 10-30-2008
361. 20080268051 HIGH VISCOSITY MACROMOLECULAR COMPOSITIONS FOR TREATING OCULAR CONDITIONS 10-30-2008
362. 20080260832 SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR PREVENTING RETINAL DYSFUNCTION 10-23-2008
363. 20080255601 Apparatus and method for remote deflation of intragastric balloon 10-16-2008
364. 20080255239 SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS 10-16-2008
365. 20080255230 THERAPEUTIC FLUOROETHYLCYANO GUANIDINES - Disclosed herein is compound having a formula as described herein 10-16-2008
366. 20080255220 Therapeutic Substituted Gamma Lactams - Disclosed herein is a compound comprising or a pharmaceutically acceptable salt or a prodrug thereof 10-16-2008
367. 20080241252 METHODS AND COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION TO TREAT OCULAR CONDITIONS 10-02-2008
368. 20080221152 4-(HETEROARYL-METHYL AND SUBSTITUTED HETEROARYL-METHYL)-IMIDAZOLE-2-THIONES ACTING AS ALPHA2 ADRENERGIC AGONISTS 09-11-2008
369. 20080214781 LEUCINE-BASED MOTIF AND CLOSTRIDIAL NEUROTOXINS 09-04-2008
370. 20080213830 Degradable Clostridial Toxins - The specification discloses modified Clostridial toxins comprising a PAR ligand domain a Clostridial toxin enzymatic 09-04-2008
371. 20080213796 GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity 09-04-2008
372. 20080213315 CLOSTRIDIAL TOXIN PHARMACEUTICAL COMPOSITIONS 09-04-2008
373. 20080213313 BOTULINUM TOXIN TREATMENTS - method and composition for treating a patient suffering from a disease disorder or condition and associated pain include 09-04-2008
374. 20080213312 BOTULINUM TOXIN TREATMENTS - method and composition for treating a patient suffering from a disease disorder or condition and associated pain include 09-04-2008
375. 20080207628 METHODS OF PREVENTING AND REDUCING THE SEVERITY OF STRESS-ASSOCIATED CONDITIONS 08-28-2008
376. 20080207627 METHODS OF PREVENTING AND REDUCING THE SEVERITY OF STRESS-ASSOCIATED CONDITIONS 08-28-2008
377. 20080207561 NOVEL BIOMATERIALS AND A METHOD FOR MAKING AND USING SAME 08-28-2008
378. 20080207495 CYCLOSPORIN COMPOSITIONS FOR OCULAR ROSACEA TREATMENT 08-28-2008
379. 20080207494 Cyclosporin Compositions - Cyclosporin A compositions are disclosed herein comprising an oil and a surfactant 08-28-2008
380. 20080206224 MUSCLE CONTRACTION TREATMENT UTILIZING BOTULINUM TOXIN 08-28-2008
381. 20080199498 METHODS FOR TREATING EYE DISORDERS - methods of treating an eye disorder 08-21-2008
382. 20080199453 BOTULINUM TOXIN COMPOSITIONS AND METHODS 08-21-2008
383. 20080199452 BOTULINUM TOXIN COMPOSITIONS AND METHODS 08-21-2008